NM_000548.5:c.3968C>T

Variant names:

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_000548.5(TSC2):c.3968C>T(p.Ala1323Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,611,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1323T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 34)

Exomes 𝑓: 0.000042 ( 0 hom. )

Consequence

TSC2
NM_000548.5 missense

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 1.33

Publications

5 publications found

Variant links:

Genes affected

TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

TSC2 Gene-Disease associations (from GenCC):

tuberous sclerosis
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
tuberous sclerosis 2
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
lymphangioleiomyomatosis
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
tuberous sclerosis complex
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

TSC2 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4

Computational evidence support a benign effect (MetaRNN=0.08003533).

BP6

Variant 16-2083779-C-T is Benign according to our data. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2083779-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 65083.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BS2

High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TSC2	NM_000548.5 link	c.3968C>T	p.Ala1323Val	missense_variant	Exon 33 of 42	ENST00000219476.9	NP_000539.2	P49815-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TSC2	ENST00000219476.9 link	c.3968C>T	p.Ala1323Val	missense_variant	Exon 33 of 42	5	NM_000548.5	ENSP00000219476.3		P49815-1

Frequencies

GnomAD3 genomes

AF:

0.0000460

AC:

AN:

152186

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000724

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.000193

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000441

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000571

AC:

AN:

245348

AF XY:

0.0000376

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.0000293

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.000330

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.0000542

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000418

AC:

AN:

1458990

Hom.:

Cov.:

AF XY:

0.0000482

AC XY:

AN XY:

725578

show subpopulations

African (AFR)

AF:

0.0000597

AC:

AN:

33476

American (AMR)

AF:

0.0000225

AC:

AN:

44512

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26058

East Asian (EAS)

AF:

0.000177

AC:

AN:

39650

South Asian (SAS)

AF:

0.0000583

AC:

AN:

85740

European-Finnish (FIN)

AF:

0.00

AC:

AN:

52014

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5746

European-Non Finnish (NFE)

AF:

0.0000387

AC:

AN:

1111486

Other (OTH)

AF:

0.0000497

AC:

AN:

60308

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.475

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000460

AC:

AN:

152186

Hom.:

Cov.:

AF XY:

0.0000403

AC XY:

AN XY:

74350

show subpopulations

African (AFR)

AF:

0.0000724

AC:

AN:

41456

American (AMR)

AF:

0.00

AC:

AN:

15284

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3470

East Asian (EAS)

AF:

0.000193

AC:

AN:

5190

South Asian (SAS)

AF:

0.00

AC:

AN:

4832

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10622

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.0000441

AC:

AN:

68022

Other (OTH)

AF:

0.00

AC:

AN:

2086

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.511

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.000116

Hom.:

Bravo

AF:

0.0000680

ExAC

AF:

0.0000414

AC:

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:9Other:1

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Tuberous sclerosis 2

Benign:3

Jan 29, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Nov 07, 2021

Genome-Nilou Lab

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Jun 02, 2025

Myriad Genetics, Inc.

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -

not specified

Benign:2

Dec 03, 2022

Quest Diagnostics Nichols Institute San Juan Capistrano

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

The frequency of this variant in the general population (http://gnomad.broadinstitute.org) is higher than would generally be expected for pathogenic variants in this gene. Computational tools predict this amino acid change may be benign. -

Jan 27, 2017

GeneDx

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hereditary cancer-predisposing syndrome

Benign:2

Oct 01, 2021

Sema4, Sema4

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:curation

- -

Nov 13, 2020

Ambry Genetics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Ovarian cancer

Benign:1

Jan 01, 2022

Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Benign:1

Mar 01, 2025

CeGaT Center for Human Genetics Tuebingen

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

TSC2: BP4 -

Tuberous sclerosis syndrome

Other:1

Tuberous sclerosis database (TSC2)

Significance:not provided

Review Status:no classification provided

Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.076

BayesDel_addAF

Benign

-0.16

BayesDel_noAF

Benign

-0.15

CADD

Benign

(source)

DANN

Benign

0.89

DEOGEN2

Benign

0.40

T;.;.;.;.;.;.;.;.;.;.;.;T;.;T

Eigen

Benign

-0.82

Eigen_PC

Benign

-0.80

FATHMM_MKL

Benign

0.14

LIST_S2

Benign

0.80

T;T;T;T;T;T;T;T;T;T;T;T;T;T;T

M_CAP

Uncertain

0.15

MetaRNN

Benign

0.080

T;T;T;T;T;T;T;T;T;T;T;T;T;T;T

MetaSVM

Benign

-0.67

MutationAssessor

Benign

0.76

N;.;.;.;.;.;.;.;.;.;.;.;.;.;.

PhyloP100

1.3

PrimateAI

Benign

0.30

PROVEAN

Benign

-0.63

N;.;.;N;.;N;.;.;N;N;.;.;.;.;N

REVEL

Uncertain

0.43

Sift

Benign

0.25

T;.;.;T;.;T;.;.;T;T;.;.;.;.;T

Sift4G

Benign

0.56

T;.;.;T;.;T;.;.;T;T;.;.;.;.;T

Polyphen

0.56

P;.;.;.;B;B;.;.;B;B;.;.;.;.;.

Vest4

0.072

MutPred

0.23

Loss of helix (P = 0.0376);.;.;.;.;.;.;Loss of helix (P = 0.0376);.;.;.;.;.;.;.;

MVP

0.74

ClinPred

0.024

GERP RS

4.1

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

1.1

Varity_R

0.029

gMVP

0.27

Mutation Taster

=93/7

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over